Winton Group’s BioTelemetry, Inc. BEAT Stock Holding History

Winton Group’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,018	Closed	-$362K	–	1492
2020 Q4	$362K	Buy	+5,018	New	+$263K	0.03%	957
2018 Q3	–	Sell	-13,125	Closed	-$591K	–	1211
2018 Q2	$591K	Sell	13,125 -10,813	-45%	-$431K	0.02%	589
2018 Q1	$743K	Buy	+23,938	New	+$787K	0.02%	614

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Winton Group's BEAT Position: Q1 2021 in Review

Winton Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 5,018 shares — an estimated $362K sold.

Winton Group first reported a position in BEAT in Q1 2018 and held it in 3 quarters. The position peaked at $743K in Q1 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Winton Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Winton Group sold 5,018 BioTelemetry, Inc. shares in Q1 2021, an estimated $362K.
Winton Group first reported a position in BioTelemetry, Inc. in Q1 2018 and held it in 3 quarters.
Winton Group's BioTelemetry, Inc. position peaked at $743K in Q1 2018.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Winton Group's 13F filing for Q1 2021, filed 21 Jul 2021.